Indeterminable international normalized ratio with concurrent use of warfarin and gatifloxacin.
Chock
Alan W Y
AW
School of Pharmacy and Health Professions, Creighton University Medical Center, Omaha, NE 68178, USA. chock@creighton.edu
Stading
Julie A
JA
D000369:Aged, 80 and over; D000890:Anti-Infective Agents / Q000009:adverse effects / Q000627:therapeutic use; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D024841:Fluoroquinolones / Q000009:adverse effects / Q000627:therapeutic use*; D000077734:Gatifloxacin; D006801:Humans; D019934:International Normalized Ratio; D008297:Male; D012307:Risk Factors; D013997:Time Factors; D014859:Warfarin / Q000009:adverse effects / Q000627:therapeutic use*
D000890:Anti-Infective Agents; D000925:Anticoagulants; D024841:Fluoroquinolones; D014859:Warfarin; D000077734:Gatifloxacin